Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for inherited immunodeficiencies.

Steven Howe1, Adrian J Thrasher

  • 1Molecular Immunology Unit, Institute of Child Health, 30 Guilford Street, London WCIN 1EH, UK. s.howe@ich.ucl.ac.uk

Current Hematology Reports
|August 7, 2003
PubMed
Summary

Gene therapy shows promise for inherited immunologic diseases, with successes in treating specific conditions. Further research is needed to overcome challenges and advance gene therapy for primary immunodeficiencies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapeutic activity of a hematopoietic stem cell-delivered cell-penetrating frataxin in Friedreich's ataxia models.

Cell reports. Medicine·2026
Same author

Anti-CD45 PBD-based antibody-drug conjugates are effective targeted conditioning agents for gene therapy and stem cell transplant.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Long-term efficacy and safety results of betibeglogene autotemcel gene therapy for transfusion-dependent β-thalassemia.

Blood·2026
Same author

Lentiviral Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1.

Obstetrical & gynecological survey·2025
Same author

Lentiviral Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1.

Obstetrical & gynecological survey·2025
Same author

Long-Term Safety and Efficacy of Gene Therapy for Adenosine Deaminase Deficiency.

The New England journal of medicine·2025

Area of Science:

  • Immunology
  • Genetics
  • Molecular Biology
  • Gene Therapy

Background:

  • Gene therapy research has yielded limited clinical successes.
  • Understanding of inherited immunologic diseases has advanced.
  • Gene transfer and stem cell manipulation techniques have improved.

Purpose of the Study:

  • To review gene therapy progress for primary immunodeficiencies.
  • To identify challenges in current gene therapy approaches.
  • To discuss future directions for gene therapy in this field.

Main Methods:

  • Literature review of gene therapy studies.
  • Analysis of successes in treating specific immunodeficiencies.
  • Discussion of technological advancements and limitations.

Main Results:

  • Successful gene therapy applications exist for X-linked severe combined immunodeficiency and adenosine deaminase deficiency.
  • Significant challenges remain in broader clinical application.
  • Advances in genetic understanding and stem cell technology are crucial.

Conclusions:

  • Gene therapy holds potential for treating primary immunodeficiencies.
  • Overcoming technical and safety hurdles is essential for future success.
  • Continued research is vital to improve efficacy and accessibility.

Related Experiment Videos